|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ReportAboutTheUseOfTheFundObtainedOrWillBeObtainedFromCapitalIncreaseAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|http://www.xbrl.org/2003/role/terseLabel
|
|
.
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
In accordance with Article 33 of the CMB Communiqué No. VII-128.1 on Shares, the actual utilization of the proceeds obtained from the capital increase, as set forth in the prospectus approved by the Capital Markets Board on 16.10.2025, has been presented in the attached report prepared by the Audit Committee. Our Company has utilized the portion of the proceeds obtained through the rights issue and public offering in line with the use of funds as disclosed in the prospectus. Respectfully submitted for the information of the general public and investors.
|
||||||||